GABRIELA HINOJOSA: Open Payments
NPI 1154052009 · MISSION, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$274 in 15 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $193 · 2025 $274
Food & beverage: $274
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $66 |
| Exact Sciences Corporation | 3 | $50 |
| Globus Medical, Inc. | 1 | $28 |
| PFIZER INC. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Madrigal Pharmaceuticals | 1 | $17 |
| Novo Nordisk Inc | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: Cologuard Collection Kit, MOUNJARO, Senza, PAXLOVID, AREXVY, JARDIANCE, REZDIFFRA, Ozempic.
Industry payments across TX — which companies pay providers there.
